- Price
- $50.40
- Day
- -2.82%
- Mkt Cap
- $1.51B
- 52W Range
- $31.44 – $56.64
- Volume
- 453.5K
- Beta
- 0.93
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Arrowstreet Capital Limited Partnership lifted its position in shares of CONMED Corporation (NYSE: CNMD) by 217.6% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 419,092 shares of the company's stock after buying an additional 287,150 shares during the quarter. Arrowstreet Capital
Read full article
CONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript
Read full article
CNMD's Q2 earnings and revenues beat estimates, while margin growth and solid international sales support a higher 2026 EPS outlook.
Read full article
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today reported financial results for the second quarter ended June 30, 2026 and updated its financial guidance for the full year ending 2026. Second Quarter 2026 Highlights(1) Sales of $343.5 million increased 0.3% year-over-year as reported and decreased 0.5% on a constant currency(2) basis. Excluding the impact of the Company's previously announced strategic exits of GI product offerings, net sales increased 6.0% on an organic cons.
Read full article
CONMED NYSE: CNMD reported second-quarter 2026 net sales of $343.5 million, up 0.3% on a reported basis but down 0.5% in constant currency. Organic sales, which exclude the company's exited gastroenterology product offerings, rose 6% year over year and modestly exceeded management's expectations.
Read full article
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read full article
Conmed (CNMD) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.15 per share a year ago.
Read full article
CNMD's FDA-expanded AirSeal indication adds da Vinci 5 hex cannula compatibility, supporting broader use across Intuitive Surgical's robotic systems.
Read full article
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its AirSeal® Robotic Solution is now indicated for use with Intuitive's 8 mm hex cannulas used as part of the Intuitive da Vinci 5 platform (“dV5”). Alongside its existing indication for Intuitive 8 mm round cannulas, the AirSeal Robotic Solution now has an expanded indication for use across Intuitive's portfolio of da Vinci X, da Vinci Xi, and da Vinci 5 robotic systems. Building on the existing indication for I.
Read full article
CONMED Corporation (NYSE: CNMD) today announced that its [url="]AirSeal Robotic Solution[/url] is now indicated for use with Intuitive's 8 mm hex cannulas us
Read full article
Allspring Global Investments Holdings LLC grew its position in shares of CONMED Corporation (NYSE: CNMD) by 39.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 582,733 shares of the company's stock after buying an additional 166,301 shares during the quarter.
Read full article
Bessemer Group Inc. boosted its position in CONMED Corporation (NYSE: CNMD) by 46.5% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 116,429 shares of the company's stock after purchasing an additional 36,940 shares during the period. Bessemer Group Inc. owned about 0.39% of CONMED worth
Read full article